Tech Company Financing Transactions

Alvine Pharmaceuticals Funding Round

On 3/31/2010, Alvine Pharmaceuticals received $2.6 million in financing from InterWest Partners, Panorama Capital and Sofinnova Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

75 Shoreway Rd. B
San Carlos, CA 94070
USA

Phone

(650) 632-1645

Website

www.alvinepharma.com

Email Address

Not Recorded

Overview

Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Abhay Joshi

        

Chief Medical Officer

Daniel Adelman

        

VP - Finance

David Southern

        

VP - Marketing

Kirk Essenmacher

        

VP - Regulatory Affairs

Henk Kocken

        

VP - Sales

James Watson

        

Browse more venture capital transactions:

Prev: 3/31/2010: Purfresh venture capital transaction
Next: 3/31/2010: Tangent Energy Solutions venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary